Eastgate Biotech Corp. (ETBI)

OTCMKTS · Delayed Price · Currency is USD
0.0010
+0.0009 (900.00%)
At close: Feb 20, 2026
-77.78%
Market Cap 1.06M
Revenue (ttm) 137.64K
Net Income (ttm) -3.82M
Shares Out 1.06B
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 540,000
Average Volume 1,394,195
Open 0.0010
Previous Close 0.0001
Day's Range 0.0010 - 0.0010
52-Week Range 0.0000 - 0.0045
Beta -3,995.34
RSI 49.58
Earnings Date n/a

About Eastgate Biotech

Eastgate Biotech Corp., a development stage company, develops novel formulations of natural compounds and pharmaceutical products. The company is developing pharmaceutical products, such as Lorazepam oral spray for acute seizures emergency treatment; Ketoconazole 2% topical ointment for treatment of skin fungal infections; and Metformin chewable/ sublingual tablets for treatment of type 2 diabetes. It is also developing natural products and dietary supplements, including E-drops Nano and PURALEN that are self-nanoemulsifying compositions contai... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 3
Stock Exchange OTCMKTS
Ticker Symbol ETBI
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.